Vivozon Pharmaceutical Co., Ltd. announced a private placement that it will issue 2,915,452 common shares at an issue price of KRW 686 for the total gross proceeds of KRW 2,000,000,072 on January 9, 2023. The company will issue shares through third-party allotment and have a holding period of 1 year. The transaction has been approved by the board of the directors.

The transaction is expected to close on February 28, 2023.